Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest James Thomson Stories

2014-04-08 08:30:32

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/92nl6r/opportunities_in) has announced the addition of the "Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017" [http://www.researchandmarkets.com/research/92nl6r/opportunities_in ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Embryonic stem cells are stem cells...

2013-11-21 20:21:28

DUBLIN, November 21, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/jbgncn/opportunities_in) has announced the addition of the "Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017" [http://www.researchandmarkets.com/research/jbgncn/opportunities_in ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Stem cells are primitive cells found in all...

2013-10-04 23:18:34

RnRMarketResearch.com adds latest report on “Opportunities in Human Embryonic Stem Cell (hESC) Products – Trends and Forecasts to 2017” to its store. Dallas, TX (PRWEB) October 04, 2013 This report is available at a flat 10% Discount on all license types till October 31, 2013. Listed above are original prices and the discount is applicable on the same. Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to...

2013-09-03 16:27:02

WASHINGTON, Sept. 3, 2013 /PRNewswire-USNewswire/ -- A patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF) "covers ineligible subject matter and was anticipated by and obvious" in view of earlier research, Consumer Watchdog and the Public Patent Foundation have told a federal appeals court. In a reply brief filed late last week in the U.S. Court of Appeals for the Federal Circuit seeking to invalidate the '913 patent issued by the Patent and...

2013-08-15 23:23:57

MarketResearch.com announces the addition of a new market research report in Biotechnology to their product offering: Opportunities in Human Embryonic Stem Cell Products; http://www.marketresearch.com/land/product.asp?productid=7713367&progid=85709. Rockville, MD (PRWEB) August 15, 2013 Opportunities in Human Embryonic Stem Cell Products. Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reached four to five days...

2013-08-13 10:36:10

Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers from the Morgridge Institute for Research and Northwestern University have created an efficient way to target and repair defective genes. Writing today in the Proceedings of the National Academy of Sciences, the team reports that the novel technique is much simpler than previous methods and establishes the groundwork for major advances in regenerative medicine, drug screening and biomedical...

2013-06-05 08:29:04

MADISON, Wis., June 5, 2013 /PRNewswire/ -- Cellular Dynamics International (CDI) today announced that it has expanded its MyCell® Products line, offering access to a number of human disease models and licensing key genetic engineering patents from Life Technologies and Sigma-Aldrich. CDI's MyCell Products include custom cell products manufactured using induced pluripotent stem cell (iPSC) technology to make stem cells or differentiated cells from any individual, including those with...

2013-05-24 23:04:43

Under the new agreement, CDI now can make use of, distribute, sublicense and sell cellular products that employ the licensed technology for therapeutic use. New York, NY (PRWEB) May 24, 2013 The Icahn School of Medicine at Mount Sinai has granted Cellular Dynamics International (CDI) exclusive license rights to commercially develop cardiomyocyte progenitors for in vivo cell therapy and regenerative medicine applications. These cells are capable of further differentiation into the multiple...

2013-03-21 08:30:45

MADISON, Wis., March 21, 2013 /PRNewswire/ -- Cellular Dynamics International (CDI) and Coriell Institute for Medical Research today announced receiving two multi-million dollar grant awards from the California Institute for Regenerative Medicine (CIRM). CIRM awarded CDI $16 million to create 3 induced pluripotent stem cell (iPSC) lines for each of 3000 healthy and diseased donors. Tissue samples will be taken from patients suffering from Alzheimer's disease, autism spectrum disorders,...

2013-03-08 08:23:18

MADISON, Wis., March 8, 2013 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI), a leading commercial producer of human induced pluripotent stem cell (iPSC) lines and tissue cells for drug discovery, safety, stem cell banking and cellular therapeutics, today announced scientific presentations at the Society of Toxicology's 52(nd) Annual Meeting (SOT), March 10 to 14 in San Antonio, that demonstrate the expanding utility of CDI's iCell® products on toxicology assay development....